awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34523319-811BF9D3-CD1D-41CB-9DEB-5103378B9562
Q34523319-811BF9D3-CD1D-41CB-9DEB-5103378B9562
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34523319-811BF9D3-CD1D-41CB-9DEB-5103378B9562
Antiangiogenic therapy for glioblastoma: current status and future prospects.
P2860
Q34523319-811BF9D3-CD1D-41CB-9DEB-5103378B9562
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34523319-811BF9D3-CD1D-41CB-9DEB-5103378B9562
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cac83deb73f7e1d50d026e5c614936bc999a2482
P2860
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial.